{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:12:53Z","timestamp":1781115173495,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970282, 82270331"],"award-info":[{"award-number":["81970282, 82270331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00960-1","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:50:06Z","timestamp":1750553406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal timing for atrial fibrillation patients to undergo catheter ablation"],"prefix":"10.1038","volume":"5","author":[{"given":"Mingjie","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongshuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7832-1425","authenticated-orcid":false,"given":"Jingquan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,22]]},"reference":[{"key":"960_CR1","doi-asserted-by":"publisher","unstructured":"Joglar, J. A. et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, https:\/\/doi.org\/10.1161\/CIR.0000000000001193 (2023).","DOI":"10.1161\/CIR.0000000000001193"},{"key":"960_CR2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer, D. L. et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 321, 1261\u20131274 (2019).","journal-title":"JAMA"},{"key":"960_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373\u2013498 (2021).","journal-title":"Eur. Heart J."},{"key":"960_CR4","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18, 1609\u20131678 (2016).","journal-title":"Europace"},{"key":"960_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche, N. F. et al. Catheter ablation for atrial fibrillation with heart failure. N. Engl. J. Med. 378, 417\u2013427 (2018).","journal-title":"N. Engl. J. Med."},{"key":"960_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.hrthm.2024.04.058","volume":"21","author":"E Bulhoes","year":"2024","unstructured":"Bulhoes, E. et al. Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart Rhythm 21, 1595\u20131603 (2024).","journal-title":"Heart Rhythm"},{"key":"960_CR7","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","volume":"79","author":"AJ Camm","year":"2022","unstructured":"Camm, A. J. et al. The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review. J. Am. Coll. Cardiol. 79, 1932\u20131948 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"960_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof, P. et al. Early rhythm-control therapy in patients with atrial fibrillation. N. Engl. J. Med. 383, 1305\u20131316 (2020).","journal-title":"N. Engl. J. Med."},{"key":"960_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","volume":"146","author":"A Rillig","year":"2022","unstructured":"Rillig, A. et al. Early rhythm control in patients with atrial fibrillation and high comorbidity burden. Circulation 146, 836\u2013847 (2022).","journal-title":"Circulation"},{"key":"960_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","volume":"43","author":"S Willems","year":"2022","unstructured":"Willems, S. et al. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Eur. Heart J. 43, 1219\u20131230 (2022).","journal-title":"Eur. Heart J."},{"key":"960_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02545-4","volume":"20","author":"W Zhu","year":"2022","unstructured":"Zhu, W., Wu, Z., Dong, Y., Lip, G. Y. H. & Liu, C. Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. BMC Med. 20, 340 (2022).","journal-title":"BMC Med."},{"key":"960_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2212540","volume":"388","author":"JG Andrade","year":"2023","unstructured":"Andrade, J. G. et al. Progression of atrial fibrillation after cryoablation or drug therapy. N. Engl. J. Med 388, 105\u2013116 (2023).","journal-title":"N. Engl. J. Med"},{"key":"960_CR13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder, I. C. et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 45, 3314\u20133414 (2024).","journal-title":"Eur. Heart J."},{"key":"960_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","volume":"6","author":"MK Turagam","year":"2021","unstructured":"Turagam, M. K. et al. Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: a meta-analysis of randomized clinical trials. JAMA Cardiol. 6, 697\u2013705 (2021).","journal-title":"JAMA Cardiol."},{"key":"960_CR15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.hrthm.2013.05.013","volume":"10","author":"TJ Bunch","year":"2013","unstructured":"Bunch, T. J. et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart Rhythm 10, 1257\u20131262 (2013).","journal-title":"Heart Rhythm"},{"key":"960_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2459\/JCM.0000000000000688","volume":"19","author":"M Lunati","year":"2018","unstructured":"Lunati, M. et al. Is the time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation a predictor of efficacy? J. Cardiovasc. Med. 19, 446\u2013452 (2018).","journal-title":"J. Cardiovasc. Med."},{"key":"960_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/jce.14000","volume":"30","author":"F Bisbal","year":"2019","unstructured":"Bisbal, F. et al. Diagnosis-to-ablation time in atrial fibrillation: a modifiable factor relevant to clinical outcome. J. Cardiovasc. Electrophysiol. 30, 1483\u20131490 (2019).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"960_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003669","volume":"9","author":"AA Hussein","year":"2016","unstructured":"Hussein, A. A. et al. Radiofrequency ablation of persistent atrial fibrillation: diagnosis-to-ablation time, markers of pathways of atrial remodeling, and outcomes. Circ. Arrhythm. Electrophysiol. 9, e003669 (2016).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"960_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/europace\/euw426","volume":"20","author":"Y De Greef","year":"2018","unstructured":"De Greef, Y. et al. Diagnosis-to-ablation time as a predictor of success: early choice for pulmonary vein isolation and long-term outcome in atrial fibrillation: results from the Middelheim-PVI Registry. Europace 20, 589\u2013595 (2018).","journal-title":"Europace"},{"key":"960_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jce.15810","volume":"34","author":"AJ Sessions","year":"2023","unstructured":"Sessions, A. J. et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart disease. J. Cardiovasc. Electrophysiol. 34, 507\u2013515 (2023).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"960_CR21","doi-asserted-by":"publisher","unstructured":"Zhou, L. et al. Impact of diagnosis-to-ablation time on clinical outcomes in patients with early-onset atrial fibrillation. Clin. Cardiol. https:\/\/doi.org\/10.1002\/clc.24194 (2023).","DOI":"10.1002\/clc.24194"},{"key":"960_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijcard.2019.03.036","volume":"291","author":"T Kawaji","year":"2019","unstructured":"Kawaji, T. et al. Early choice for catheter ablation reduced readmission in management of atrial fibrillation: Impact of diagnosis-to-ablation time. Int. J. Cardiol. 291, 69\u201376 (2019).","journal-title":"Int. J. Cardiol."},{"key":"960_CR23","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/eurheartj\/ehad247","volume":"44","author":"JM Kalman","year":"2023","unstructured":"Kalman, J. M. et al. Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences. Eur. Heart J. 44, 2447\u20132454 (2023).","journal-title":"Eur. Heart J."},{"key":"960_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.amjcard.2020.09.036","volume":"137","author":"B Rong","year":"2020","unstructured":"Rong, B. et al. Thromboembolic risk of cessation of oral anticoagulation post catheter ablation in patients with and without atrial fibrillation recurrence. Am. J. Cardiol. 137, 55\u201362 (2020).","journal-title":"Am. J. Cardiol."},{"key":"960_CR25","doi-asserted-by":"publisher","first-page":"e1005","DOI":"10.1016\/S2468-2667(24)00043-4","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Early adulthood BMI and cardiovascular disease: a prospective cohort study from the China Kadoorie Biobank. Lancet Public Health 9, e1005\u2013e1013 (2024).","journal-title":"Lancet Public Health"},{"key":"960_CR26","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893\u20132962 (2016).","journal-title":"Eur. Heart J."},{"key":"960_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2022.23722","volume":"329","author":"PM Kistler","year":"2023","unstructured":"Kistler, P. M. et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA 329, 127\u2013135 (2023).","journal-title":"JAMA"},{"key":"960_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jamacardio.2023.1749","volume":"8","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation: a randomized clinical trial. JAMA Cardiol. 8, 765\u2013772 (2023).","journal-title":"JAMA Cardiol."},{"key":"960_CR29","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","volume":"61","author":"DL Packer","year":"2013","unstructured":"Packer, D. L. et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J. Am. Coll. Cardiol. 61, 1713\u20131723 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"960_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","volume":"35","author":"S Nattel","year":"2014","unstructured":"Nattel, S. et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur. Heart J. 35, 1448\u20131456 (2014).","journal-title":"Eur. Heart J."},{"key":"960_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2019.05.112","volume":"517","author":"QQ Jie","year":"2019","unstructured":"Jie, Q. Q. et al. Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation. Biochem. Biophys. Res. Commun. 517, 8\u201314 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"960_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2217\/fca-2021-0034","volume":"18","author":"S Roman","year":"2022","unstructured":"Roman, S. et al. Rate versus rhythm control for atrial fibrillation: from AFFIRM to EAST-AFNET 4 - a paradigm shift. Future Cardiol. 18, 354\u2013353 (2022).","journal-title":"Future Cardiol."},{"key":"960_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011585","volume":"16","author":"J Dickow","year":"2023","unstructured":"Dickow, J. et al. Outcomes of early rhythm control therapy in patients with atrial fibrillation and a high comorbidity burden in large real-world cohorts. Circ. Arrhythm. Electrophysiol. 16, e011585 (2023).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"960_CR34","doi-asserted-by":"publisher","unstructured":"Crawford, M. et al. Mortality benefit with AF ablation: impact of normal sinus rhythm seen in CABANA and EAST AFnet. J. Cardiovasc. Electrophysiol. https:\/\/doi.org\/10.1111\/jce.16160 (2023).","DOI":"10.1111\/jce.16160"},{"key":"960_CR35","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang, A., Green, J. B., Halperin, J. L. & Piccini, J. P. Sr Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J. Am. Coll. Cardiol. 74, 1107\u20131115 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"960_CR36","doi-asserted-by":"publisher","unstructured":"Oraii, A. et al. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad811 (2024).","DOI":"10.1093\/eurheartj\/ehad811"},{"key":"960_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101582","volume":"48","author":"K Fatima","year":"2023","unstructured":"Fatima, K. et al. The effect of sodium-glucose co-transporter 2 inhibitors on stroke and atrial fibrillation: a systematic review and meta-analysis. Curr. Probl. Cardiol. 48, 101582 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"960_CR38","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","volume":"138","author":"M Lei","year":"2018","unstructured":"Lei, M., Wu, L., Terrar, D. A. & Huang, C. L. Modernized classification of cardiac antiarrhythmic drugs. Circulation 138, 1879\u20131896 (2018).","journal-title":"Circulation"},{"key":"960_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","volume":"145","author":"M Aguilar","year":"2022","unstructured":"Aguilar, M. et al. Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design. Circulation 145, 21\u201330 (2022).","journal-title":"Circulation"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00960-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00960-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:50:07Z","timestamp":1750553407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00960-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00960-1","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}